Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.

Random-forest LOOCV 87% sensitive for residual disease vs surgical pathology.

NPJ Precis Oncol 2023;7(1):6.PubMed 36658307